IBM Partners With Boehringer Ingelheim to Test Blockchain in Clinical Recordkeeping

A new partnership between IBM and Boehringer Ingelheim aims to test whether blockchain provides a proper level of data integrity, transparency, and patient safety.

The Canadian unit of American tech giant IBM has partnered with pharmaceutical company Boehringer Ingelheim to deploy blockchain in clinical recordkeeping, according to a press release published on Feb. 12.

The cooperation between the two companies aims to test whether the integration of blockchain technology with clinical recordkeeping provides the proper level of data integrity, transparency, and patient safety, in addition to reducing costs and automating processes.

Dr. Uli Broedl, Vice President, Medical and Regulatory Affairs, Boehringer Ingelheim (Canada) said, “The clinical trial ecosystem is highly complex as it involves different stakeholders, resulting in limited trust, transparency and process inefficiencies without true patient…

Read Full Story : News

2019-02-12 21:25:00

What do you think?

0 points
Upvote Downvote

Written by Cointelegraph

QuadrigaCX ‘Inadvertently’ Sent BTC to Dead CEO’s Cold Wallet: EY Report

Mainstream Crypto Boost: Spend App Supports Litecoin for Over 40 Million Merchants